Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Genetics

The BCHE Gene and Diagnosis

At a Glance

Hereditary butyrylcholinesterase deficiency is diagnosed using biochemical blood tests that measure enzyme activity (like the Dibucaine Number) and molecular genetic testing that maps the BCHE gene. DNA sequencing provides a definitive diagnosis to help predict anesthesia reactions.

Understanding how hereditary butyrylcholinesterase deficiency is diagnosed requires looking at both your blood chemistry and your DNA. Because this condition is asymptomatic (shows no symptoms) in daily life, doctors use specific laboratory tests to “stress test” your enzymes or read your genetic code [1][2].

The Genetics: Autosomal Recessive Inheritance

This condition is caused by variations in the BCHE gene, located on chromosome 3 [3]. It follows an autosomal recessive inheritance pattern [4]. This means:

  • Two Copies: To have the most severe form of the deficiency, you typically must inherit two “faulty” copies of the gene—one from your mother and one from your father [4][5].
  • The Carrier State: If you inherit only one faulty copy, you are a “carrier.” Carriers usually have enough working enzyme to handle anesthesia normally, though they may break down the drugs slightly more slowly than others [6][7].

What about my children?

Because this is an inherited condition, your biological children may be affected, particularly if your partner is also a carrier [4][1]. Since children often require routine procedures (like tonsillectomies or ear tubes) that involve anesthesia, it is highly recommended to have them tested via a simple blood test or genetic swab before they undergo any surgery [8][9].

Biochemical Testing: The Inhibition Numbers

When a doctor suspects this deficiency, they first perform a biochemical phenotype test. This is not a DNA test; instead, it measures how your enzyme behaves in a test tube when exposed to certain “inhibitors.”

The Dibucaine Number

Dibucaine is a local anesthetic that inhibits (stops) the work of normal BChE enzymes.

  • Normal Enzyme: Dibucaine will stop about 70–80% of the enzyme’s activity. This is called a “normal Dibucaine Number” [2].
  • Atypical Enzyme: If you have the “atypical” genetic variant, the enzyme is resistant to dibucaine. It might only be inhibited by 20% [8][10].
  • Why it matters: A low Dibucaine Number is a “smoking gun” for the atypical variant of the condition [2].

The Fluoride Number

Some rare variants are resistant to fluoride instead of dibucaine. Doctors use the Fluoride Number to identify these specific “F-variants,” which also cause prolonged paralysis but might be missed if only dibucaine is used [9][11].

Molecular Genetic Testing: The Definitive Map

While biochemical tests tell us how your enzyme acts, molecular genetic testing (DNA sequencing) tells us exactly what your gene is [2][8].

Modern guidelines increasingly recommend DNA sequencing because:

  1. Precision: It identifies the exact mutation (such as the “Atypical,” “Silent,” or “Kalow” variants), which helps predict exactly how long you might be paralyzed during surgery [6][9].
  2. Family Planning: It allows for precise testing of family members to see if they are carriers or also at risk [1][9].
  3. Clarity: It can distinguish between a genetic deficiency and “acquired” deficiency (caused by liver disease or pregnancy), which can sometimes look the same on biochemical tests [7][12].

Checklist for Your Diagnostic Report

When you receive your lab results, check to see if they include the following three key components. Having all three provides the most complete picture for your medical record:

Component What it tells you
Total BChE Activity The raw amount of working enzyme in your blood [2].
Inhibition Numbers Specifically the Dibucaine and Fluoride numbers [9].
Genotype The specific DNA sequence of your BCHE gene [4].

If your report is missing any of these, ask your doctor if further testing is needed to ensure you have a “definitive” diagnosis for your records [9][2].

Common questions in this guide

What does a low Dibucaine Number mean on my lab report?
A low Dibucaine Number indicates that your enzymes are resistant to dibucaine, which is a strong sign of the 'atypical' variant of BCHE deficiency. In a normal enzyme, dibucaine stops about 70 to 80 percent of its activity.
Do my children need to be tested for BCHE deficiency?
Because BCHE deficiency is an inherited genetic condition, your biological children may be affected or be carriers. It is highly recommended to have them tested with a simple blood test or genetic swab before they undergo any routine surgeries requiring anesthesia.
What is the difference between being a carrier and having BCHE deficiency?
To have the most severe form of the deficiency, you typically inherit two faulty copies of the BCHE gene. A carrier inherits only one faulty copy and usually produces enough working enzyme to handle anesthesia normally, though they may break down drugs slightly slower.
Why is DNA testing recommended over just a standard blood test?
While biochemical tests show how your enzymes act in a test tube, DNA sequencing identifies your exact genetic mutation. This helps doctors predict exactly how you will react to anesthesia and distinguishes true genetic deficiency from temporary deficiencies caused by pregnancy or liver disease.
What information should my BCHE diagnostic lab report include?
A complete diagnostic report should include your total BChE enzyme activity, your inhibition numbers (like the Dibucaine or Fluoride number), and your specific genotype or DNA sequence.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which specific BCHE variant did you find in my genetic test (e.g., Atypical, Silent, or Kalow)?
  2. 2.What is my Dibucaine Number, and how does it compare to the 'normal' range of 70-80?
  3. 3.Is my deficiency classified as homozygous (two copies) or heterozygous (one copy), and how does that change my risk for future surgeries?
  4. 4.Does my laboratory report include both total enzyme activity and inhibition numbers?
  5. 5.Should we schedule genetic counseling to discuss testing for my biological children or siblings?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Pseudocholinesterase Deficiency - Is Succinylcholine Still Needed to Facilitate Endotracheal Intubation?

    Kurnutala LN, Rugnath N

    Cureus 2020; (12(9)):e10721 doi:10.7759/cureus.10721.

    PMID: 33150117
  2. 2

    Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.

    Mintjens N, Brummans R, Soetens F, et al.

    Acta anaesthesiologica Scandinavica 2021; (65(2)):182-187 doi:10.1111/aas.13718.

    PMID: 33010031
  3. 3

    A novel BCHE frameshift mutation in a Chinese woman with butyrylcholinesterase deficiency: A case report and literature review.

    Zeng J, Yang D, Dai T, et al.

    Medicine 2024; (103(40)):e39976 doi:10.1097/MD.0000000000039976.

    PMID: 39465744
  4. 4

    Hereditary pseudocholinesterase deficiency in a 4-year-old girl: a case report.

    Schulze-Berge J, Pillong L, Busse B, et al.

    Journal of medical case reports 2025; (19(1)):145 doi:10.1186/s13256-025-05183-5.

    PMID: 40148900
  5. 5

    Butyrylcholinesterase deficiency.

    Delacour H, Dedome E, Courcelle S, et al.

    Annales de biologie clinique 2016; (74(3)):279-85 doi:10.1684/abc.2016.1141.

    PMID: 27237801
  6. 6

    Genetic Testing for BCHE Variants Identifies Patients at Risk of Prolonged Neuromuscular Blockade in Response to Succinylcholine.

    Zhu GD, Dawson E, Huskey A, et al.

    Pharmacogenomics and personalized medicine 2020; (13()):405-414 doi:10.2147/PGPM.S263741.

    PMID: 33061533
  7. 7

    Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.

    Andersson ML, Møller AM, Wildgaard K

    Anaesthesia 2019; (74(4)):518-528 doi:10.1111/anae.14545.

    PMID: 30600548
  8. 8

    Prolonged paralysis following mivacurium administration in a pediatric patient with previously undiagnosed pseudocholinesterase deficiency: a case report.

    Uzun DD, Wildenberg K, Ruping F, et al.

    BMC pediatrics 2025; (25(1)):619 doi:10.1186/s12887-025-05996-9.

    PMID: 40790181
  9. 9

    Genotype-phenotype relationships in butyrylcholinesterase deficiency: a systematic review.

    Snak de Souza CD, Ibarra Moreno CA, Riazi S, Hopkins PM

    British journal of anaesthesia 2026; (137(2)):450-459 doi:10.1016/j.bja.2026.03.056.

    PMID: 42120224
  10. 10

    [Prolonged neuromuscular block in a patient with butyrylcholinesterase deficiency].

    Mabboux I, Hary B, Courcelle S, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2016; (23(5)):497-500.

    PMID: 27017361
  11. 11

    New Insights into Butyrylcholinesterase Activity Assay: Serum Dilution Factor as a Crucial Parameter.

    Jońca J, Żuk M, Wasąg B, et al.

    PloS one 2015; (10(10)):e0139480 doi:10.1371/journal.pone.0139480.

    PMID: 26444431
  12. 12

    The First-Known Case of Hereditary Heterozygous Butyrylcholinesterase Deficiency in a Patient on Dialysis.

    Tokunaga N, Shima H, Okamoto T, et al.

    Cureus 2024; (16(1)):e53153 doi:10.7759/cureus.53153.

    PMID: 38420074

This page explains BCHE gene testing and diagnosis for educational purposes. Your geneticist or anesthesiologist is the best source for interpreting your specific lab results and planning safe anesthesia care.

Get notified when new evidence is published on Hereditary butyrylcholinesterase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.